Jean-Philippe Bouchara, Bernard Cimon and Dominique Chabasse

Slides:



Advertisements
Similar presentations
HEART TRANSPLANTATION
Advertisements

FUNGAL DISEASES IN THE RESPIRATORY , EXCRETORY & CIRCULATORY SYSTEMS
HEART-LUNG TRANSPLANTATION Overall ISHLT 2006 J Heart Lung Transplant 2006;25:
LUNG TRANSPLANTATION Pediatric Recipients ISHLT 2006 J Heart Lung Transplant 2006;25:
HEART-LUNG TRANSPLANTATION Overall ISHLT 2005 J Heart Lung Transplant 2005;24:
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART TRANSPLANTATION Pediatric Recipients.
2004 ISHLT J Heart Lung Transplant 2004; 23: HEART-LUNG TRANSPLANTATION Overall.
2003 ISHLT J Heart Lung Transplant 2003; 22: HEART-LUNG TRANSPLANTATION Overall.
HEART-LUNG TRANSPLANTATION Overall ISHLT 2008 J Heart Lung Transplant 2008;27:
HEART TRANSPLANTATION Pediatric Recipients ISHLT 2007 J Heart Lung Transplant 2007;26:
HEART-LUNG TRANSPLANTATION
Decreasing the burden of allergy
Chronic pulmonary aspergillosis
Fungal infections in COPD
Invasive mycoses in cystic fibrosis and lung transplant
Aspergillosis in AIDS David W. Denning
Chronic pulmonary aspergillosis
Neurological toxicity of Tri-azole Antifungals DR CAROLINE BAXTER Clinical Research Fellow
RADIOLOGY - CXR Bronchiectasis - vessel ‘crowding’
Prevention of Ventilator Associated Pneumonia
Asthma in Minnesota Slide Set Asthma Program Minnesota Department of Health January 2013.
Treatment of Fungal infections in Hematologic Malignancies
HIV and Aging Kathleen K Casey, MD Director, AIDS Ambulatory Care Center Jersey Shore University Medical Center.
Roswell Park Cancer Institute
Infection in COPD Pulmonology Subspeciality Rounds (12/11/2008)Dr.Krock Dr.Vysetti Dr.Vysetti.
ALLERGIC BRONCHOPULMONARY ASPERGILLOSIS
Airborne fungi infections Dr David W. Denning FRCP FRCPath Scientific Advisor to the Fungal Research Trust Clinician, Wythenshawe Hospital Head, Antifungal.
Respiratory Fungal Infections Dr. Ahmed Al-Barrag Asst. Professor of Medical Mycology School of Medicine and the University Hospitals King Saud University.
بسم الله الرحمن الرحيم Medical mycology
How Important is Aspergillus in Cystic Fibrosis? Richard B Moss MD Department of Pediatrics Stanford University Palo Alto CA, USA.
POSITIONAL CLONING TWO EXAMPLES. Inheritance pattern - dominant autosomal Entirely penetrant and fatal Frequency - about 1/10,000 live births Late onset.
Respiratory Fungal Infections
Aspergillosis infection
Respiratory Fungal Infections
Invasive Aspergillosis
Immunology of Asthma Immunology Unit Department of Pathology King Saud University.
Immunology of Asthma Dr. Hend Alotaibi Assistant Professor & Consultant College of Medicine, King Saud University Dermatology Department /KKUH
Dr Abdalla Elfateh Ibrahim Consultant and assistant Professor Of Pulmonary Medicine.
Bronchiectasis Sami ur Rahman Roll No: Overview Definition Etiology Pathology Clinical Presentation Diagnosis Treatment.
Fungal infections 400 out of 75,000 Primary infections Opportunistic infections Myco-toxins Allergy.
POSITIONAL CLONING TWO EXAMPLES. Inheritance pattern - dominant autosomal Entirely penetrant and fatal Frequency - about 1/10,000 live births Late onset.
Clinical manifestation and diagnosis of bronchiectasis Aleš Rozman University Clinic of Respiratory Diseases and Allergy, GOLNIK, Slovenia Portorož – 9th.
neoformans causes cryptococcal meningitis. C neoformans is an oval, budding yeast surrounded by a wide polysaccharide.
Opportunistic Pathogens –Aspergillus species. Aspergillosis is an infection caused by Aspergillus, a common mold that lives indoors and outdoors. Most.
Aspergillosis Aspergillosis is a spectrum of diseases of humans and animals caused by members of the genus Aspergillus. These include (1) mycotoxicosis.
PHL 437/Pharmacogenomics First Lecture (Asthma I) By Abdelkader Ashour, Ph.D. Phone:
Bronchial asthma By Dr. Abdelaty Shawky Assistant professor of pathology.
Hospital-acquired Invasive Aspergillosis: How Big is the Problem?
CPC #2: Shortness of breath, fevers, chills, and rigors Barbara J. Crain, M.D., Ph.D. October 6, 2009.
How It Is Spread  Burkholderia cepacia is spread by a person, typically not with the best health, doing an activity involving water and soil containing.
Aspergillus  Aspergillus is a filamentous, hyaline mold.  It can grow on dead leaves, stored grain, and other decaying vegetation.  Large numbers of.
ASPERGILLOSIS Prof. Khaled H. Abu-Elteen ASPERGILLOSIS Aspergilli produce a wide variety of diseases. Like the zygomycetes, they are ubiquitous in nature.
RESPIRATORY FUNGAL INFECTION. YEASTMOULD FUNGIDIMORPHIC FUNGI OpportunisticPrimary Infectious Candidiasis (Candida and other yeast) Aspergillosis (Aspergillus.
Respiratory Fungal Infections
Hot Topics in Antibiotic Management of Pediatric CF Lung Disease Mike Tracy, MD Fellow, Pediatric Pulmonary.
Timothy W. Felton, Caroline Baxter, Caroline B. Moore, Stephen A.Roberts, William W. Hope,and David W. Denning Clinical Infectious Diseases 2010; 51:1383–1391.
Pulmonary Infiltrates with Eosinophilia
Allergic Bronchopulmonary Aspergillosis (ABPA)
Immunology Unit Department of Pathology King Saud University
Respiratory diseases caused by fungi
Pulmonary Zygomycosis
Respiratory Fungal Infections
Mycology Lec. 4 Dr. Manahil
The Challenges of Fungi in Cystic Fibrosis
Allergic Bronchopulmonary Aspergillosis: Management
Lecturer name: Dr. Ahmed M. Albarrag
Lecturer name: Dr. Ahmed M. Albarrag
Immunology Unit Department of Pathology King Saud University
Immunology Unit Department of Pathology King Saud University
Presentation transcript:

Filamentous fungi and chronic respiratory infections in cystic fibrosis Jean-Philippe Bouchara, Bernard Cimon and Dominique Chabasse Host-Parasite Interaction Study Group, UPRES-EA 3142 Angers University Hospital http://www.med.univ-angers.fr/GEIHP/ XVI ISHAM Congress, Paris, June 25-29th

Chronic respiratory infections in CF The most common genetic inhereted disease in the European Caucasian population The third orphan disease in France Due to mutations in the gene CFTR (Cystic Fibrosis Transmembrane Conductance Regulator) Modifications of the electrolytic exchanges Defect in the mucociliairy clearance and thickeness of the bronchial mucus Entrapment of the inhaled bacteria and fungal spores

Chronic respiratory infections in CF Staphylococcus aureus, Pseudomonas aeruginosa Burkholderia cepacia Lm Fn Fg Fungal spores neutrophils Inflammatory reaction Elastase Bacterial proteases Bouchara et al., Contrib Microbiol, 1999 Lm Fn

Aspergillus fumigatus and cystic fibrosis The major causative agent of colonization of the airways 9 to 57% of the patients Becker et al., Chest, 1996 : 16% - USA Milla et al., Pediatr Pulmonol, 1996 : 21.2% - USA Burns et al., Clin Infect Dis, 1998 : 24.5% - USA Cimon et al., Eur J Med Microbiol Infect Dis, 2000 : 46.1% - France Bakare et al., Mycoses, 2003 : 45.7% - Germany Responsible for various diseases in the context of CF Asthma, bronchiitis and aspergilloma Invasive pulmonary aspergillosis (after lung transplantation) Allergic broncho-pulmonary aspergillosis or ABPA

Aspergillus fumigatus and cystic fibrosis Prevalence of ABPA : from 0.9 to 11% of CF patients Laufer et al., J Allergy Clin Immunol, 1984 10.0% Simmonds et al., Arch Dis Child, 1990 5.8% Marchant et al., Thorax, 1994 6.8% Mroueh et Spock, Chest, 1994 6.5% Becker et al., Chest, 1996 1.9% Hutcheson et al., Chest, 1996 5.1% Cimon et al., J Mycol Med, 2000 3.9% Skov et al., Allergy, 2000 10.9% Great variations in the criteria used for diagnosis of the disease

Cystic Fibrosis Foundation Consensus Conference Aspergillus fumigatus and cystic fibrosis Cystic Fibrosis Foundation Consensus Conference June 2001 (Bethesda, Ma) Minimal diagnostic criteria Acute or subacute clinical deterioration (cough, wheeze, exercise intolerance, exercise-induced asthma, change in pulmonary function, or increased sputum production) not attributable to another etiology + Elevated total serum IgE concentration (> 500 UI/ml) + immediate cutaneous reactivity to Aspergillus or presence of specific serum IgE + presence of specific serum IgG or new or recent abnormalities on chest radiography (infiltrates or mucus plugging) or chest CT (bronchiectasis) that are not cured with antibiotics Stevens et al., Clin Infect Dis, 2003

Aspergillus fumigatus and cystic fibrosis Chauhan et al., J Allegy Clin Immunol, 2000 HLA-DR molecules DR2, DR5 (and DR4 or DR7) contribute to susceptibility to APBA, while HLA-DQ2 contributes to resistance Combination of genetic events determines the outcome of ABPA Knutsen et al., Clin Mol Allergy, 2006 Polymorphism in the Il-4 receptor a chain (substitution I75V) constitutes a genetic risk for ABPA Brouard et al., J Infect Dis, 2005 Polymorphism in the promoter region of Il-10 gene may influence the host response to A. fumigatus Relationship between the -1082GG genotype and both ABPA and airway colonization by A. fumigatus

Aspergillus fumigatus and cystic fibrosis Genotype study of multiple and sequential isolates Sequence-specific DNA primer and RAPD (primers NS3 and NS7) Recently colonized patients Huge diversity of genotypes even in the same sample (frequency and diversity of genotypes of A. fumigatus in the environment) With the ageing colonization A dominant genotype, common to the chronically colonized patients, tends to settle Associated with the presence of serum anti-A. fumigatus catalase antibodies (marker of altered lung function) Cimon et al., J Med Microbiol, 2001

Aspergillus fumigatus and cystic fibrosis Neuvéglise et al., Eur J Clin Microbiol Infect Dis, 1997 Restriction fragment length polymorphism (EcoRI) followed by hybridization with the repetitive l 3.9 probe 2 4 6 8 10 1993 1994 1995 1996 03.02 04.01 04.21 05.10 06.04 07.29 11.29 01.10 02.10 03.07 03.21 05.18 05.30 07.10 09.25 10.23 12.13 01.15 01.26 02.15 03.05 03.13 04.23 06.07 06.17 09.26 Number of isolates Some genotypes seem to be selected with the ageing colonization Mechanisms of this genotype selection ?

Chronic respiratory infections in CF Collaboration with Renée Sabran Hospital (Giens) - Transversal study (210 patients) Mycological examination of sputum samples and search for precipitating antibodies directed towards pathogenic aspergilli or S. apiospermum Cimon et al., J Mycol Méd, 1995 - Longitudinal study (128 patients followed during 5 years) Cimon et al., Eur J Med Microbiol Infect Dis, 2000 Angers Giens Procedure used for mycological examination of sputum samples : Inoculation of the sample on two YPDA plates supplemented, for one plate, with 0.1% cycloheximide Incubation at 37°C for 7 days

Scedosporium apiospermum and cystic fibrosis Transversal Longitudinal study study Aspergillus fumigatus 21.4 46.1 Scedosporium apiospermum 3.3 8.6 Aspergillus terreus 1.9 6.2 Up to 10% in Australia (Williamson et al., J Clin Microbiol, 2001) Usually associated with A. fumigatus (10 out of 11 patients) Emerged subsequently to A. fumigatus in 9 patients (average delay : 14 months) Improvement of its detection by the use of cycloheximide

Scedosporium apiospermum and cystic fibrosis Origin of the contamination of the patients ? - Highly polluted soils and water - Rarely encountered in indoor environment Study of the air and surfaces in 130 dwellings in Brussels Never found from surface samples Recovered only once in the air (ranked 49th among 52 genera identified, 1 CFU among 20,000) Beguin and Nolard, Aerobiologia, 1994

Scedosporium apiospermum and cystic fibrosis Environmental study at home of 6 patients with CF colonized by S. apiospermum, and followed in Angers University Hospital Air (patient’s bedroom, bathroom and livingroom) : 2 x 1 m3 per site Water (shower, bathtub) : 500 ml per sample Surface samples (bedroom, bathroom and livingroom) : 10 sites per house or flat Soil samples : soil from all potted plants present at home

Scedosporium apiospermum and cystic fibrosis 164 samples analyzed Air, water and surface samples : Only one (from a radiator in the bedroom of one patient) revealed the presence of Scedosporium apiospermum Soil samples : P1 P2 P3 P4 P5 P6 Potted plants 9 5 10 7 13 11 Positive samples 8 4 5 6 7 8 38 out of the 55 potted plants studied were positive

Evasion to the host immune response Invasion of the host tissues Scedosporium apiospermum and cystic fibrosis Adherence to the host tissues Evasion to the host immune response Invasion of the host tissues Colonization and/or infection Subtilisin-like serine protease Larcher et al., Biochem J, 1994 Cu,Zn cytoplasmic superoxide dismutase Lima et al., manuscript in preparation

Scedosporium apiospermum and cystic fibrosis Responsible for a chronic colonization of the airways Usually a unique genotype different from one patient to another, and conserved over time despite the antifungal treatment Sometimes associated with one or two other genotypes, found occasionally and closely related to the dominant genotype Defontaine et al., J Clin Microbiol, 2002 Unrelated isolates Patient 4 S1 S2 S3

Scedosporium apiospermum and cystic fibrosis Usually no clinical signs Cerebral or disseminated mycoses in immunocompromised patients Allergic broncho-pulmonary mycoses Cimon et al., Eur J Clin Microbiol Infect Dis, 2000 Even in the absence of respiratory infection, one can’t disregard the colonization of the airways by S. apiospermum - contributes to the inflammatory reaction - "contra-indication" to lung transplantation Precipitin lines ( ) FEV1 (% ) Eosinophils (cells/mm3 ) 1500 1000 500 10 20 30 40 50 80 60 8 6 4 2 Itra

Scedosporium apiospermum and cystic fibrosis CF patient, 26-year old, chronically colonized by S. apiospermum In April 1999, double-lung transplantation Antibacterial and antifungal prophylaxis (itraconazole orally and aerosols of amphotericin B) 4 weeks later: bilateral chorioretinitis and subcutaneous nodules Vitreal fluid and biopsies of the cutaneous lesions S. apiospermum Voriconazole (400 mg/day) during six months Two days after the end of the treatment, sub-acute meningitis Isolation of S. apiospermum from the cerebrospinal fluid Voriconazole again, but the patient died three weeks later Symoens et al., J Heart Lung Transplant, 2006

Scedosporium apiospermum and cystic fibrosis Unrelated isolates Patient with CF M 1 2 3 4 5 6 7 8 9 10 11 12 13 M 7-11: sputum samples 7: 8: 9: 1999, April 4 10: 1999, April 7 11: 1999, April 16 12-13: vitreal fluid 1999, May 1997 1999, April 1 UBC 701 UBC 703

Chronic respiratory infections in CF Aspergillus species : Aspergillus terreus A. flavus, A. niger, A. nidulans (transiently recovered) Scedosporium prolificans (mainly reported in Spain) Garcia et al., Enferm Infecc Microbiol Clin, 1998 Del Palacio et al., Mycoses, 2001 Lopez et al., Enferm Infecc Microbiol Clin, 2001 Transient colonization Fetal invasive infection after lung transplantation (Vagefi et al., Am J Ophthalmol, 2005 )

Penicillium emersonii and cystic fibrosis Biverticillate asymerical penicilli Phialides with a cylindrical base and a tapering tip Smooth cylindrical conidia Isolated repeatedly from sputum samples in a CF patient for nearly five years progressive sensitization to the fungus revealed by Western-blotting Cimon et al., Med Mycol, 1999

Acrophialophora fusispora and cystic fibrosis In CF, transient colonization of the airways in a 11-year old patient González-Escalada et al. Rev Iberoam Micol, 2000 Cimon et al., J Clin Microbiol, 2005 Detected in 4 patients (a 26-year old patient followed in Giens, and the others in Paris) All patients were also colonized by A. fumigatus, and A. fusispora was isolated repeatedly in one patient Prevalence low, maybe underestimated because of misidentifications with Scopulariopsis spp., Paecilomyces spp. or S. prolificans Guarro & Gené, J Clin Microbiol, 2002; Sigler & Sutton, J Clin Microbiol, 2002

Acrophialophora fusispora and cystic fibrosis Long chains of lemon-shaped or fusiform conidia, with ornamentations arranged in spiral bands Pale buff colonies of 5 to 6 cm in diameter at day 7 Basally inflated phialides, arising mostly singly on vegetative hyphae

Exophiala dermatitidis and cystic fibrosis Mainly reported in Germany Low prevalence in The Netherlands (1.8%) Mouton et al., 20th EWGCF, Brussels, June 1995 7.5% Haase et al., Lancet, 1990 9.1% Haase et al., Mycoses, 1991 15.7%Blaschke-Hellmessen et al., Mycoses, 1994 6.2% Horre et al., Respiration, 2004 Differences in geographic distribution of the fungus ? or lack of standardization of the mycological examination of sputum samples (slow growth: 1- to 4-week incubation) Transient or chronic colonization, usually without any clinical signs Pneumonia or invasive pulmonary mycoses Diemert et al., Scand J Infect Dis, 2001 -Kusenbach et al., Eur J Pediatr, 1992

Exophiala dermatitidis and cystic fibrosis Patient with bronchiectasis, and repeated episodes of bronchial infections requiring a lobectomy in June 1997 May 2003, hospitalization due to a new episode of hemoptysis July 2003, sputum sample exclusive and profuse growth of E. dermatitidis Similar results on successive samples (Dec 2003, Feb 2004, May 2004) Retrospective serological study (somatic extract): 3 to 6 precipitin lines by CIE since June 2003 and no reactivity with A. fumigatus extract Itraconazole treatment (200 mg/day from November 2003 to June 2004) Improvement of the patient which was cured in May 2004

Biomarkers of a CF-related disease Exophiala dermatitidis and cystic fibrosis The regular isolation of E. dermatitidis from this patient (65-year old) with bronchiectasis and repeated episodes of bronchial infections led us to search a CF-related disease Sequencing of the gene CFTR revealed for both alleles minor mutations L206W (exon 6A) / V754M (exon 13) Filamentous fungi like E. dermatitidis or some Aspergillus or Scedosporium species isolated from respiratory secretions from patients with bronchiectasis Biomarkers of a CF-related disease

Host-Parasite Interaction Study Group, Angers Chronic respiratory infections in CF Host-Parasite Interaction Study Group, Angers Véronique Apaire Bernard Cimon Dominique Chabasse Gérald Larcher Patricia Licznar Guy Tronchin PhD students : Marc Pihet Post-doctoral fellows : Osana Lima, Rachid Zouhair Collaborations Pediatric and Adult CF Units of Angers University Hospital Renée Sabran Hospital (Giens, France) Françoise Symoens (IHEM, Brussels, Belgium) Alain Defontaine (University of Nantes, France) http://www.med.univ-angers.fr/GEIHP/